Also listed on Velicept Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Oct 24, 2036 · High confidence
20-year base term ends Oct 24, 2036
Oct 24, 2016
Oct 24, 2036
Oct 7, 2025
This patent's term runs 210 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 24, 2016, when application 15/332,956, the earliest non-provisional in its chain, was filed (this one was filed May 18, 2023) | Oct 24, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +210 days, USPTO patent term adjustment record | May 22, 2037 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,065,922, US 10,221,126, US 10,844,004, US 11,691,944) | capped to Oct 24, 2036 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 24, 2036 | High confidence |
This family
| US 10,065,922 | Lapsed on the fee record Sep 2026 | Sep 2026 |
| US 10,221,126 | In force Oct 2036 | Oct 2036 |
| US 10,844,004 | In force Oct 2036 | Oct 2036 |
| US 11,691,944 | In force Oct 2036 | Oct 2036 |
| US 12,435,026 | this patent Oct 2036 | Oct 2036 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 12, 2023 Reel 63926, frame 193 | Mobele, Bingidimi Itute; Rondaxe Pharma, LLC | Velicept Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jun 12, 2023 Reel 63926, frame 347 | Velicept Therapeutics, Inc. | Velicept (Assignment for the Benefit of Creditors), LLC | Assignment of Assignor's Interest |
| Jun 12, 2023 Reel 63926, frame 390 | Velicept (Assignment for the Benefit of Creditors), LLC; Velicept Therapeutics, Inc. | B3AR Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jun 12, 2023 Reel 64559, frame 900 | Zhao, Dalian; J-Star Research, Inc. | Velicept Therapeutics, Inc. | Assignment of Assignor's Interest |
| Aug 11, 2023 Reel 64567, frame 397 | Stevens, Raymond E. | Velicept Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,065,922, US 10,221,126, US 10,844,004, US 11,691,944.